Elisabetta Dejana1,2,3, Maria Grazia Lampugnani4,5. 1. FIRC Institute of Molecular Oncology, University of Milan, Milan, Italy. elisabetta.dejana@ifom.eu. 2. Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. 3. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. 4. FIRC Institute of Molecular Oncology, University of Milan, Milan, Italy. 5. Mario Negri Institute for Pharmacological Research Milan, Italy.
Authors: Mario Tirone; Anna Giovenzana; Arianna Vallone; Paola Zordan; Martina Sormani; Pier Andrea Nicolosi; Raffaela Meneveri; Carmen Rosaria Gigliotti; Antonello E Spinelli; Renata Bocciardi; Roberto Ravazzolo; Ingrid Cifola; Silvia Brunelli Journal: Front Immunol Date: 2019-07-19 Impact factor: 7.561
Authors: Jin Ma; Gerard van der Zon; Manuel A F V Gonçalves; Maarten van Dinther; Midory Thorikay; Gonzalo Sanchez-Duffhues; Peter Ten Dijke Journal: Front Cell Dev Biol Date: 2021-02-12
Authors: Anthony C Y Yau; Maria Ascencion Globisch; Favour Chinyere Onyeogaziri; Lei L Conze; Ross Smith; Suvi Jauhiainen; Monica Corada; Fabrizio Orsenigo; Hua Huang; Melanie Herre; Anna-Karin Olsson; Matteo Malinverno; Veronica Sundell; Behnam Rezai Jahromi; Mika Niemelä; Aki Laakso; Cecilia Garlanda; Alberto Mantovani; Maria Grazia Lampugnani; Elisabetta Dejana; Peetra U Magnusson Journal: Cell Mol Life Sci Date: 2022-03-25 Impact factor: 9.207